Accueil > Publications > Recherche par années > Années 2010 > 2013

Collet G., Grillon C., Nadim M. and Kieda C.

Trojan horse at cellular level for tumor gene therapies

Gene 525 (2) 208-216 - doi : 10.1016/j.gene.2013.03.057

par Frapart - publié le , mis à jour le

Abstract :

Among innovative strategies developed for cancer treatments, gene therapies stand of great interest despite their well-known limitations in targeting, delivery, toxicity or stability. The success of any given genetherapy is highly dependent on the carrier efficiency. New approaches are often revisiting the mythic trojan horse concept to carry therapeutic nucleic acid, i.e. DNAs, RNAs or small interfering RNAs, to pathologic tumor site. Recent investigations are focusing on engineering carrying modalities to overtake the above limitations bringing new promise to cancer patients. This review describes recent advances and perspectives for gene therapies devoted to tumor treatment, taking advantage of available knowledge in biotechnology and medicine.